SHARE

Philip Morris doubles Colorado investment to $1.2bn for Zyn production

The tobacco company is doubling its Colorado investment to $1.2bn through 2028, expanding production capacity for Zyn nicotine pouches. The move follows FDA authorisation of 20 Zyn products as less harmful than cigarettes.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.